
Keywords: پروسه; Plasmacytoid dendritic cells; rhinovirus; IFN-α; asthma; IgE; omalizumab; FcεRα; IRF; Interferon regulatory factor; pDC; Plasmacytoid dendritic cell; PROSE; Preventative Omalizumab or Step-Up Therapy for Fall Exacerbations; RIG-I; Retinoic acid-induc